IP Library › Assignment 028907/0566
Patent Assignment
Reel/Frame 028907/0566

Assignment of Assignor's Interest

Recorded: 2012-09-06 Pages: 4
Assignor
DYAX CORP.
Executed: 2010-02-17
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
Antibodies Against ERBB3 and Uses Thereof
Patent: 8,961,966 →
Application: 12/904,492 →
Publication: US 2011/0123523
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 6, 2012
From: SCHOEBERL, BIRGIT; NIELSEN, ULRIK; FELDHAUS, MICHAEL
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 028907/0541 →
Assignment of Assignor's Interest Sep 6, 2012
From: MURUGANANDAM, ARUMUGAM; BUCKLER, DAVID
To: DYAX CORP.
Reel/Frame 028907/0553 →
Security Interest Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Release of Security Interest Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →
Assignment of Assignor's Interest Aug 12, 2019
From: MERRIMACK PHARMACEUTICALS, INC.
To: 14NER ONCOLOGY, INC.
Reel/Frame 050024/0722 →